Decreased Total and Corrected Antioxidant Capacity in Patients with Inflammatory Bowel Disease

Overview

Journal Dig Dis Sci

Specialty Gastroenterology

Date 2004 Oct 16

PMID 15481315

Citations 46

Authors

Ioannis E Koutroubakis

Niki Malliaraki

Philippos D Dimoulios

Konstantinos Karmiris

Elias Castanas

Elias A Kouroumalis

Affiliations

Soon will be listed here.

Abstract

Oxidative stress and depletion of antioxidants may play a key role in the pathogenesis of inflammatory bowel disease (IBD)-related intestinal damage. A new automated assay for the determination of blood total antioxidant capacity (TAC), based on the crocin bleaching method, has been used for the measurement of TAC and corrected TAC (cTAC) in patients with ulcerative colitis (UC) and Crohn's disease (CD) in comparison to healthy controls (HC). Ninety-four patients with UC, 97 patients with CD, and 72 HC were included in this study. Serum TAC was measured in all patients and controls on an Olympus AU-600 chemistry analyzer using a TAC kit. cTAC was calculated from TAC after subtraction of the interactions due to endogenous uric acid, bilirubin and albumin. Mean serum TAC as well as cTAC levels were significantly lower in both UC and CD patients compared with HC (P < 0.0001). Patients with active UC had no different TAC and cTAC compared to those with inactive disease. Patients with active CD had significantly lower mean TAC compared to those with inactive disease but cTAC was not different between the two phases of disease activity. Patients with proctitis had significantly higher TAC and cTAC compared to patients with left-sided colitis and total colitis. In CD patients no association between disease localization and these markers was found. TAC and cTAC are significantly reduced in IBD patients compared with controls irrespective of disease activity. The decreased antioxidant defenses may be a primary phenomenon severely compromising the mucosa and therefore increase susceptibility to oxidative tissue damage.

Citing Articles

Nutraceutical Impact of Pumpkin Seed Oil on Expression Levels of EZH-2 and KRT-14 Genes against DSS-induced Inflammatory Bowel Disease in the Rat Model.

Mukhtar A, Mukhtar I, Muzaffar H, Faisal M, Khan K, Nawaz L Cell Biochem Biophys. 2025; .

PMID: 39865190 DOI: 10.1007/s12013-024-01629-7.

A Paper-Based Assay for the Determination of Total Antioxidant Capacity in Human Serum Samples.

Tran M, Gomez S, Alenicheva V, Remcho V Biosensors (Basel). 2024; 14(11).

PMID: 39590018 PMC: 11591649. DOI: 10.3390/bios14110559.

Rutin Ameliorates Inflammation and Oxidative Stress in Ulcerative Colitis by Inhibiting NLRP3 Inflammasome Signaling Pathway.

Zhao X, Chen X, Yue C Cell Biochem Biophys. 2024; 82(4):3715-3726.

PMID: 39138797 PMC: 11576901. DOI: 10.1007/s12013-024-01459-7.

Serum urate is associated with an increased risk of inflammatory bowel disease: A bidirectional Mendelian randomization study.

Zhang S, Fang X, Kang L, Sui X, Liu M, Luo Y World J Clin Cases. 2024; 12(5):891-902.

PMID: 38414603 PMC: 10895627. DOI: 10.12998/wjcc.v12.i5.891.

The Oxidative Stress and Nervous Distress Connection in Gastrointestinal Disorders.

Stavely R, Ott L, Rashidi N, Sakkal S, Nurgali K Biomolecules. 2023; 13(11).

PMID: 38002268 PMC: 10669114. DOI: 10.3390/biom13111586.

References

Buffinton G, Doe W . Altered ascorbic acid status in the mucosa from inflammatory bowel disease patients. Free Radic Res. 1995; 22(2):131-43. DOI: 10.3109/10715769509147535. View

Kruidenier L, Kuiper I, van Duijn W, Mieremet-Ooms M, van Hogezand R, Lamers C . Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease. J Pathol. 2003; 201(1):17-27. DOI: 10.1002/path.1408. View

Iantomasi T, Marraccini P, Favilli F, Vincenzini M, Ferretti P, Tonelli F . Glutathione metabolism in Crohn's disease. Biochem Med Metab Biol. 1994; 53(2):87-91. DOI: 10.1006/bmmb.1994.1062. View

Kruidenier L, Kuiper I, Lamers C, Verspaget H . Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. J Pathol. 2003; 201(1):28-36. DOI: 10.1002/path.1409. View

Koch T, Yuan L, Stryker S, Ratliff P, Telford G, Opara E . Total antioxidant capacity of colon in patients with chronic ulcerative colitis. Dig Dis Sci. 2000; 45(9):1814-9. DOI: 10.1023/a:1005517824877. View

Lennard-Jones J . Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989; 170:2-6; discussion 16-9. DOI: 10.3109/00365528909091339. View

Buffinton G, Doe W . Depleted mucosal antioxidant defences in inflammatory bowel disease. Free Radic Biol Med. 1995; 19(6):911-8. DOI: 10.1016/0891-5849(95)94362-h. View

Ahnfelt-Ronne I, Nielsen O . The antiinflammatory moiety of sulfasalazine, 5-aminosalicylic acid, is a radical scavenger. Agents Actions. 1987; 21(1-2):191-4. DOI: 10.1007/BF01974941. View

Kruidenier L, Verspaget H . Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease--radicals or ridiculous?. Aliment Pharmacol Ther. 2002; 16(12):1997-2015. DOI: 10.1046/j.1365-2036.2002.01378.x. View

10.

Seril D, Liao J, Yang G, Yang C . Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis. 2003; 24(3):353-62. DOI: 10.1093/carcin/24.3.353. View

11.

Mulder T, Verspaget H, Janssens A, de Bruin P, Pena A, Lamers C . Decrease in two intestinal copper/zinc containing proteins with antioxidant function in inflammatory bowel disease. Gut. 1991; 32(10):1146-50. PMC: 1379375. DOI: 10.1136/gut.32.10.1146. View

12.

Best W, Becktel J, SINGLETON J, KERN Jr F . Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976; 70(3):439-44. View

13.

Tuzun A, Erdil A, Inal V, Aydin A, Bagci S, Yesilova Z . Oxidative stress and antioxidant capacity in patients with inflammatory bowel disease. Clin Biochem. 2002; 35(7):569-72. DOI: 10.1016/s0009-9120(02)00361-2. View

14.

Ghiselli A, Serafini M, Natella F, Scaccini C . Total antioxidant capacity as a tool to assess redox status: critical view and experimental data. Free Radic Biol Med. 2000; 29(11):1106-14. DOI: 10.1016/s0891-5849(00)00394-4. View

15.

Walmsley R, Ayres R, Pounder R, Allan R . A simple clinical colitis activity index. Gut. 1998; 43(1):29-32. PMC: 1727189. DOI: 10.1136/gut.43.1.29. View

16.

Kitahora T, Suzuki K, Asakura H, Yoshida T, Suematsu M, Watanabe M . Active oxygen species generated by monocytes and polymorphonuclear cells in Crohn's disease. Dig Dis Sci. 1988; 33(8):951-5. DOI: 10.1007/BF01535990. View

17.

Keshavarzian A, Sedghi S, Kanofsky J, List T, Robinson C, Ibrahim C . Excessive production of reactive oxygen metabolites by inflamed colon: analysis by chemiluminescence probe. Gastroenterology. 1992; 103(1):177-85. DOI: 10.1016/0016-5085(92)91111-g. View

18.

Genser D, Kang M, Vogelsang H, Elmadfa I . Status of lipidsoluble antioxidants and TRAP in patients with Crohn's disease and healthy controls. Eur J Clin Nutr. 1999; 53(9):675-9. DOI: 10.1038/sj.ejcn.1600764. View

19.

Kampa M, Nistikaki A, Tsaousis V, Maliaraki N, Notas G, Castanas E . A new automated method for the determination of the Total Antioxidant Capacity (TAC) of human plasma, based on the crocin bleaching assay. BMC Clin Pathol. 2002; 2(1):3. PMC: 128814. DOI: 10.1186/1472-6890-2-3. View

20.

Hirayama A, Nagase S, Ueda A, Ishizu T, Taru Y, Yoh K . Oxidative stress during leukocyte absorption apheresis. J Clin Apher. 2003; 18(2):61-6. DOI: 10.1002/jca.10054. View